Gsk Annual Results 2025 Calendar
Gsk Annual Results 2025 Calendar – Portfolio Receipts growth of 12% to $608 million; Royalty Receipts growth of 11%Net cash provided by operating activities of $658 millionRaising full year 2024 guidance: Portfolio Receipts expected to . Revenue saw a significant decline due to the conclusion of a discovery term with GSK. The company reported a total adjusted EBITDA deficit of […]